Novel use of peptide compounds for treating amyotrophic lateral sclerosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050277596A1
SERIAL NO

11145965

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to the use of a class of peptide compounds for treating amyotrophic lateral sclerosis (ALS) and other forms of motoneuron diseases and peripheral neuropathies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SCHWARZ PHARMA AGD-40789 MONHEIM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Stohr, Thomas Monheim, DE 16 331

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation